Ionis Pharmaceuticals (IONS) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Ionis Pharmaceuticals (IONS)

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
4676	121	0	IONS

Emcee: Keith Fauci	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
2876	You have raised several issues here. Taking a capital loss to offset a capital	Art Bechhoefer	-	12/17/1999
2875	I can't tell from the news releases whether G3139 uses any patents that bel	Art Bechhoefer	-	12/17/1999
2874	I sold all my shares today. If it is warranted, I'll get back in January a	synchro	-	12/17/1999
2873	art, you seem like a knowledgable person. i wonder what your feelings are about	bob zagorin	-	12/16/1999
2872	John, I agree that the test results are just plain weird. Could there have bee	Art Bechhoefer	-	12/16/1999
2871	I was on the CC and that question was brought up.Management discounted that pos	John Romeo	-	12/16/1999
2870	There is still the possibility that there was a systematic error involved in th	Barron Von Hymen	-	12/16/1999
2869	That certainly isn't going to prevent the strike-suit crowd from piling on	synchro	-	12/15/1999
2868	ISIP--excerpt from Dow Jones story <<"This is clearly a setback for	kendall harmon	-	12/15/1999
2867	ISIP--looking for a bounce tomorrow <<Isis Shares Plunge as Crohn's	kendall harmon	-	12/15/1999
2866	>> the first half results, 29% remission versus 19% remission on placebo,	Micawber	-	12/15/1999
2865	Scott could you give your take on ISIS after today's news. Do you feel som	Findit	-	12/15/1999
2864	The target may be a problem for #2302, but note also in the latest GNTA press r	Art Bechhoefer	-	12/15/1999
2863	I don't think there's a basis for a lawsuit here unless it can be shown	Art Bechhoefer	-	12/15/1999
2862	Tuck, thanks for your insights. Is #2302 finished altogether, or just for Croh	Art Bechhoefer	-	12/15/1999
2861	thanks notyet, i will start tracking it. and you comment on targets makes (anti	bob zagorin	-	12/15/1999
2860	Another antisense company is ATLC. Still preclinical, though. Any antisense in	notyet	-	12/15/1999
2859	wrong target? Could it be that they targeted the wrong RNA (ICAM-1)? The best	notyet	-	12/15/1999
2858	Bob, The recent failure Kernan refers to is likely I2302 for RA. That indicat	tuck	-	12/15/1999
2857	listening to joe kernan on cnbc, he mentioned another recent failure. what was	bob zagorin	-	12/15/1999
2856	John, Thanks for the update. I would like to look and see how the composition	tuck	-	12/15/1999
2855	From the conference call: A most bewildering trial to say the least. We had the	John Romeo	-	12/15/1999
2854	Greg, It's going do be down for a good while, but not out. I don't th	tuck	-	12/15/1999
2853	Any thoughts yet about how survivable this is going to be for the company? Eve	Greg Rich	-	12/15/1999
2852	Is there any biotech manufacturing a cure for ISIP disease?	Makahadan	-	12/15/1999

Go to reply# or date (mm/dd/yy):